BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28570009)

  • 1. Mucinous cystic neoplasms of the liver and pancreas: relationship between KRAS driver mutations and disease progression.
    Fujikura K; Akita M; Abe-Suzuki S; Itoh T; Zen Y
    Histopathology; 2017 Oct; 71(4):591-600. PubMed ID: 28570009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous Cystic Neoplasms Lined by Abundant Mucinous Epithelium Frequently Involve KRAS Mutations and Malignant Progression.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Aoki T; Murakami M; Mizukami H; Tanaka JI; Takimoto M
    Anticancer Res; 2017 Dec; 37(12):7063-7068. PubMed ID: 29187496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple KRAS mutations in the non-mucinous epithelial lining in the majority of mucinous cystic neoplasms of the pancreas.
    An S; Kim MJ; Kim SJ; Sung YN; Kim YW; Song KB; Hwang DW; Kim SC; Hruban RH; Hong SM
    Histopathology; 2019 Oct; 75(4):559-567. PubMed ID: 31077597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.
    Conner JR; Mariño-Enríquez A; Mino-Kenudson M; Garcia E; Pitman MB; Sholl LM; Srivastava A; Doyle LA
    Pancreas; 2017; 46(5):665-671. PubMed ID: 28196015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.
    Singhi AD; McGrath K; Brand RE; Khalid A; Zeh HJ; Chennat JS; Fasanella KE; Papachristou GI; Slivka A; Bartlett DL; Dasyam AK; Hogg M; Lee KK; Marsh JW; Monaco SE; Ohori NP; Pingpank JF; Tsung A; Zureikat AH; Wald AI; Nikiforova MN
    Gut; 2018 Dec; 67(12):2131-2141. PubMed ID: 28970292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PIK3CA mutations in mucinous cystic neoplasms of the pancreas.
    Garcia-Carracedo D; Chen ZM; Qiu W; Huang AS; Tang SM; Hruban RH; Su GH
    Pancreas; 2014 Mar; 43(2):245-9. PubMed ID: 24518503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
    Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
    Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
    Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
    Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.
    Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational Mosaics of Cell-Free DNA from Pancreatic Cyst Fluids.
    Paziewska A; Polkowski M; Goryca K; Karczmarski J; Wiechowska-Kozlowska A; Dabrowska M; Mikula M; Ostrowski J
    Dig Dis Sci; 2020 Aug; 65(8):2294-2301. PubMed ID: 31925676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF43 as a predictor of malignant transformation of pancreatic mucinous cystic neoplasm.
    Sakihama K; Koga Y; Yamamoto T; Shimada Y; Yamada Y; Kawata J; Shindo K; Nakamura M; Oda Y
    Virchows Arch; 2022 Jun; 480(6):1189-1199. PubMed ID: 35066614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmucinous Biliary Epithelium Is a Frequent Finding and Is Often the Predominant Epithelial Type in Mucinous Cystic Neoplasms of the Pancreas and Liver.
    Zhelnin K; Xue Y; Quigley B; Reid MD; Choi H; Memis B; Adsay V; Krasinskas AM
    Am J Surg Pathol; 2017 Jan; 41(1):116-120. PubMed ID: 27673548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative characteristics and cytological features of 136 histologically confirmed pancreatic mucinous cystic neoplasms.
    Scourtas A; Dudley JC; Brugge WR; Kadayifci A; Mino-Kenudson M; Pitman MB
    Cancer Cytopathol; 2017 Mar; 125(3):169-177. PubMed ID: 27926784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Ductal Carcinoma Arising in Mucinous Cystic Neoplasm of Pancreas: A Case Report.
    Sawai H; Kurimoto M; Koide S; Kiriyama Y; Haba S; Matsuo Y; Morimoto M; Koide H; Kamiya A; Yamao K
    Am J Case Rep; 2019 Feb; 20():242-247. PubMed ID: 30798329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
    Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
    Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucinous cystic neoplasm (mucinous cystadenocarcinoma of low-grade malignant potential) of the pancreas: a clinicopathologic study of 130 cases.
    Thompson LD; Becker RC; Przygodzki RM; Adair CF; Heffess CS
    Am J Surg Pathol; 1999 Jan; 23(1):1-16. PubMed ID: 9888699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumors.
    Elias KM; Tsantoulis P; Tille JC; Vitonis A; Doyle LA; Hornick JL; Kaya G; Barnes L; Cramer DW; Puppa G; Stuckelberger S; Hooda J; Dietrich PY; Goggins M; Kerr CL; Birrer M; Hirsch MS; Drapkin R; Labidi-Galy SI
    J Pathol; 2018 Dec; 246(4):459-469. PubMed ID: 30229909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characteristics and biological behaviours of the oncocytic and pancreatobiliary subtypes of intraductal papillary mucinous neoplasms.
    Xiao HD; Yamaguchi H; Dias-Santagata D; Kuboki Y; Akhavanfard S; Hatori T; Yamamoto M; Shiratori K; Kobayashi M; Shimizu M; Fernandez-Del Castillo C; Mino-Kenudson M; Furukawa T
    J Pathol; 2011 Aug; 224(4):508-16. PubMed ID: 21547907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
    Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
    Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm.
    Taki K; Ohmuraya M; Tanji E; Komatsu H; Hashimoto D; Semba K; Araki K; Kawaguchi Y; Baba H; Furukawa T
    Oncogene; 2016 May; 35(18):2407-12. PubMed ID: 26257060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.